市场调查报告书
商品编码
1492605
马医疗保健市场:按产品、应用和最终用户 - 2024-2030 年全球预测Equine Healthcare Market by Product (Diagnostics tools, Feed Supplements, Pharmaceuticals), Application (Diagnosis, Monitoring & Therapy, Surgical Application), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年马匹保健市场规模为32.5亿美元,预计2024年将达34.6亿美元,2030年将达50.7亿美元,复合年增长率为6.52%。
马匹医疗保健包括一系列旨在维持和改善马匹健康和福利的服务、治疗和产品。兽医学专业包括马匹特有的疾病、伤害和病症的预防保健、诊断、治疗和管理。马保健的重要内容包括常规疫苗接种、牙科护理、营养护理、寄生虫控制和紧急医疗服务。马医疗保健还包括使用先进的诊断工具、外科手术、物理治疗和马匹復健。马的保健重点是预防措施和治疗性介入,对于确保马的寿命、性能和生活品质至关重要。马匹保健市场的成长是由于马术运动的日益普及、出于休閒和陪伴目的的马主数量的增加以及对动物健康和福利意识的提高而推动的。然而,严格的药品核准监管要求正在挑战马保健市场的扩张。为了维持马匹医疗保健市场的成长并满足未来的需求,将基于遗传见解的个人化远端医疗与用于远距离诊断和治疗的远距医疗相结合对于研发部门至关重要。
主要市场统计 | |
---|---|
基准年[2023] | 32.5亿美元 |
预测年份 [2024] | 34.6亿美元 |
预测年份 [2030] | 50.7亿美元 |
复合年增长率(%) | 6.52% |
区域洞察
在美洲,美国拥有大量马匹,赛马文化蓬勃发展,并在以疾病预防、治疗和福利为重点的医疗保健服务方面投入大量资金。美国正在展示马匹健康的创新,包括基因疗法和旨在早期发现和预防疾病的数位健康监测系统的最新专利。加拿大对马匹的护理和治疗实施了严格的监管标准,以确保马匹获得最高水准的医疗保健。这些法规涵盖了广泛的业务,从疾病预防和控製到动物的人道待遇。都市化的加速、可支配收入的增加以及对马术运动的兴趣日益浓厚,为亚太地区马术保健市场的扩张做出了重大贡献。中国的重点是在政府支持和私人投资的支持下改善育种方法和疾病控制。日本完善的赛马业对先进的医疗保健和治疗的需求不断增长。印度的马匹医疗保健产业受益于旨在提高品种品质和改善兽医护理基础设施的倡议,从而促进了整体市场的成长。 EMEA(欧洲、中东和非洲)地区多元化,欧盟国家传统上是马术运动和马匹医疗保健的大本营。欧洲、中东和非洲地区的马匹保健市场受到多种因素的推动,包括赛马、体育和休閒活动的日益普及,这些活动涉及需要定期健康检查和保养的马匹。先进的育种技术和预防性马匹保健在中东越来越受欢迎。中东在马匹福利、育种和医疗保健方面投入巨资,阿拉伯联合大公国等先进设施代表了所提供的高标准护理。基因研究和血统保存非常重要,并且正在分配大量资金来保护阿拉伯马的遗产和表现。在非洲地区,特别是南非,赛马界的发展和对马术运动的热情推动了马匹医疗保健的采用。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在马医疗保健市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对马保健市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在马医疗保健市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[186 Pages Report] The Equine Healthcare Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.46 billion in 2024, at a CAGR 6.52% to reach USD 5.07 billion by 2030.
Equine healthcare encompasses a broad range of services, practices, and products aimed at maintaining and enhancing the health and well-being of horses. This specialized field of veterinary medicine includes preventive care, diagnosis, treatment, and management of illnesses, injuries, and disorders specific to horses. The critical components of equine healthcare involve routine vaccinations, dental care, nutritional management, parasite control, and emergency medical services. Equine healthcare includes using advanced diagnostic tools, surgical procedures, physiotherapy, and rehabilitation for equines. With a focus on preventive measures and therapeutic interventions, equine healthcare is crucial in ensuring horses' longevity, performance, and quality of life. The growth of the equine healthcare market is driven by the rising popularity of equine sports, increased horse ownership for leisure and companionship, and a growing awareness of animal health and welfare. However, stringent regulatory requirements for drug approval act as a challenge to expanding the equine healthcare market. Personalized medicine based on genetic insights and the incorporation of telemedicine for remote diagnostics and treatment is vital for research and development areas to sustain equine healthcare market growth and address future demands.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.25 billion |
Estimated Year [2024] | USD 3.46 billion |
Forecast Year [2030] | USD 5.07 billion |
CAGR (%) | 6.52% |
Regional Insights
In the Americas, the U.S. has a substantial equine population and a prevalent horse racing culture, investing heavily in healthcare services, focusing on disease prevention, treatment, and welfare. The U.S. showcases innovations in equine health, demonstrated by the latest patents in gene therapy and digital health monitoring systems designed for early disease detection and prevention. Canada has implemented stringent regulatory standards that govern the care and treatment of equines, ensuring they receive the highest level of healthcare. These regulations cover a wide range of practices, from disease prevention and control to the humane treatment of animals. The increasing urbanization, disposable income, and a growing interest in equestrian sports have significantly contributed to expanding the equine healthcare market in the Asia Pacific region. In China, the focus remains on improving breeding methods and disease management, backed by governmental support and private investments. Japan's well-established racing industry propels the need for advanced healthcare and therapeutics. The equine healthcare sector in India is benefitting from initiatives aimed at improving breed quality and veterinary care infrastructure, contributing to the market's overall growth. The EMEA region presents a diverse picture, with EU countries traditionally strongholds in equestrian sports and, thus, equine healthcare. In the EMEA region, the equine healthcare market is driven by several factors, including the increasing popularity of horse racing, sports, and leisure activities involving horses, which necessitate regular health check-ups and maintenance. Advanced reproductive technologies and preventive equine healthcare are gaining traction in the Middle East. The Middle East invests heavily in equine welfare, breeding, and healthcare, and the advanced facilities in countries such as the United Arab Emirates epitomize the high standard of care provided. Genetic research and preservation of bloodlines are significant, with substantial funding allocated to safeguarding the heritage and performance of Arabian equines. In the African region, particularly in South Africa, the adoption of equine healthcare is propelled by the growing horse racing community and enthusiasm for equine sports.
Market Insights
The market dynamics represent an ever-changing landscape of the Equine Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Equine Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Equine Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Neogen Announced Biosecurity Partnership with TerraNova
Neogen Corporation announced a partnership with TerraNova. The partnership is poised to leverage TerraNova's innovative biosecurity solutions alongside Neogen's extensive repertoire of animal safety products, aiming to significantly elevate hygiene and disease prevention standards in equine environments. Neogen and TerraNova are dedicated to delivering unparalleled expertise and solutions through the partnership, addressing the pressing need for holistic and effective biosecurity practices in the realm of equine healthcare. [Published On: 2023-12-05]
Hilltop Bio Launched Strydaflex for Equine Joints
Hilltop Bio announced the launch of StrydaFlex, an advanced therapy explicitly designed for equine healthcare. The novel product addresses a wide range of significant health concerns that are prevalent among horses, including joint issues and inflammation, by harnessing advanced biotechnology methods. [Published On: 2023-04-25]
Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
Covetrus introduced SmartImmune Mushroom, an innovative product designed to bolster the immune defenses of horses. The latest addition to Covetrus's portfolio is the culmination of extensive research into equine health needs. SmartImmune Mushroom leverages the natural immune-supporting properties of mushrooms, offering a powerful yet holistic approach to enhance equine well-being. [Published On: 2023-04-05]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Equine Healthcare Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..
Market Segmentation & Coverage